In silico поиск новых ингибиторов полимеризации тубулина
Молекулярная биология · 2018
DOI: 10.1134/s0026898418040171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Молекулярная биология, 2018. Verfasst von H K Sahakyan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Russian-Armenian University, Yerevan, 0051 Armenia. Hauptthemen laut MEDLINE: Structure-Activity Relationship.
Abstract (Originalsprache)
Cytostatic colchicine is widely used in the treatment of Familial Mediterranean fever, but it has several side effects. For finding new, more effective drugs with higher affinity and diminishside effects we carried out virtual screening of potential inhibitors of the main target of colchicine, the polymerization of tubulin by evaluating affinity 25745 compounds, structurally related to the colchicine. We have identified 11 commercially available compounds with higher affinity to tubulin. Compounds with highest binding scores include trimethoxybenzene and its derivatives; these compounds bind to the same site in similar orientation. Information provided can form the basis for design of new cytostatics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russian-Armenian University, Yerevan, 0051 Armenia.
- Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia, Yerevan, 0014 Armenia.
- sahakyanhk@gmail.com.
- karen.nazaryan@rau.am.
Zitieren
APA
Sahakyan, H. K., Arakelov, G. G., & Nazaryan, K. B. (2018). In silico поиск новых ингибиторов полимеризации тубулина. Молекулярная биология. https://doi.org/10.1134/s0026898418040171
Vancouver
Sahakyan HK, Arakelov GG, Nazaryan KB. In silico поиск новых ингибиторов полимеризации тубулина. Молекулярная биология. 2018. doi:10.1134/s0026898418040171
BibTeX
@article{Sahakyan2018,
author = {Sahakyan, H K and Arakelov, G G and Nazaryan, K B},
title = {In silico поиск новых ингибиторов полимеризации тубулина},
journal = {Молекулярная биология},
year = {2018},
doi = {10.1134/s0026898418040171}
}
EUVIMED